Cinacalcet is associated with decreased serum FGF-23 and improved phosphorous homeostasis in patients with tumor-induced osteomalacia.

被引：0
|
作者：
Geller, JL
Cutler, C
Kelly, MH
Adams, JS
Collins, MT
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Div Endocrinol,Burns & Allen Res Inst, Los Angeles, CA USA
[2] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, DHHS, Bethesda, MD USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S177 / S177
页数：1
相关论文
共 47 条
  • [21] FGF-23 transmitted tumor - induced hypophosphatemic osteomalacia: a rare case of a young woman with recurrent fractures
    Frank, Florian
    Gerber, Lukas
    Cornelius, Alexander
    Baumhoer, Daniel
    Krieg, Andreas
    SWISS MEDICAL WEEKLY, 2022, 152 : 65S - 65S
  • [22] FGF23-Associated Tumor-Induced Osteomalacia in a Patient With Small Cell Carcinoma: A Case Report and Regulatory Mechanism Study
    Sauder, Adrienne
    Wiernek, Szymon
    Dai, Xumin
    Pereira, Renata
    Yudd, Michael
    Patel, Charvi
    Golden, Andrew
    Ahmed, Shahida
    Choe, Jin
    Chang, Victor
    Sender, Slawomir
    Cai, Donghong
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2016, 24 (02) : 116 - 120
  • [23] Tumor-Induced Osteomalacia: Treatment Progress Using Burosumab, an Anti-FGF23 Monoclonal Antibody
    Whyte, Michael P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (04) : 625 - 626
  • [24] Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia
    Hartley, Iris R.
    Roszko, Kelly L.
    Li, Xiaobai
    Pozo, Karen
    Streit, Jamie
    del Rivero, Jaydira
    Magone, M. Teresa
    Smith, Michaele R.
    Vold, Roo
    Dambkowski, Carl L.
    Collins, Michael T.
    Gafni, Rachel, I
    JBMR PLUS, 2022, 6 (08)
  • [25] EFFECTS OF KRN23, AN ANTI-FGF23 ANTIBODY, IN PATIENTS WITH TUMOR-INDUCED OSTEOMALACIA OR EPIDERMAL NEVUS SYNDROME-ASSOCIATED OSTEOMALACIA: INTERIM RESULTS FROM A PHASE 2 STUDY
    Carpenter, T.
    Miller, P. D.
    Weber, T.
    Peacock, M.
    Ruppe, M.
    Insogna, K.
    Luca, D.
    Skrinar, A.
    San Martin, J.
    de Beur, S. Jan
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S337 - S338
  • [26] Tumor-induced osteomalacia caused by an FGF23-secreting myopericytoma. Case report and literature review
    Bushart, N. Muro
    Tharun, L.
    Oheim, R.
    Paech, A.
    Kiene, J.
    ORTHOPADE, 2020, 49 (01): : 1 - 9
  • [27] FGF-23 transmitted tumor - induced hypophosphatemic osteomalacia: A rare case of a young woman with recurrent fractures and review of the literature
    Frank, Florian A.
    Gerber, Lukas
    Cornelius, Alexander
    Baumhoer, Daniel
    Krieg, Andreas H.
    JOURNAL OF BONE ONCOLOGY, 2022, 33
  • [28] Effects of Burosumab (KRN23), a Human Monoclonal Antibody to FGF23, in Patients with Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS).
    De Beur, Suzanne Jan
    Miller, Paul D.
    Weber, Thomas J.
    Peacock, Munro
    Ruppe, Mary D.
    Insogna, Karl
    Luca, Diana
    Theodore-Oklota, Christina
    San Martin, Javier
    Carpenter, Thomas
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S280 - S280
  • [29] Evaluation of Clinical Utility of Venous Sampling for FGF23 in Identifying and Confirming Responsible Tumors for Tumor-Induced Osteomalacia
    Ito, N.
    Suzuki, H.
    Shimizu, Y.
    Saito, T.
    Fukumoto, S.
    Fujita, T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S98 - S98
  • [30] Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23
    Nasu, Tetsushi
    Kurisu, Seigo
    Matsuno, Shohei
    Tatsumi, Kunihiro
    Kakimoto, Tetsuhiro
    Kobayashi, Masato
    Nakano, Yoshio
    Wakasaki, Hisao
    Furuta, Hiroto
    Nishi, Masahiro
    Sasaki, Hideyuki
    Suzuki, Hisanori
    Ito, Nobuaki
    Fukumoto, Seiji
    Nanjo, Kishio
    INTERNAL MEDICINE, 2008, 47 (10) : 957 - 961
12345